No defined discrete molecular drug target

The classification "No defined discrete molecular drug target" is utilized in pharmacological databases such as ChEMBL to identify therapeutic agents that do not interact with a specific biological macromolecule, such as a receptor, enzyme, or ion channel, to produce a clinical effect (ChEMBL, 2024). These agents typically operate through physicochemical mechanisms rather than site-specific molecular binding. For example, antacids like calcium carbonate work through simple chemical neutralization of gastric acid, while osmotic laxatives and diuretics like mannitol create physical osmotic gradients to shift fluid balance (StatPearls, 2023; PubChem, 2024). Other substances in this category include activated charcoal, which acts as a physical adsorbent for toxins, and surfactants like simethicone that change the surface tension of gas bubbles (NIH, 2023). Because these drugs lack a specific protein target, they are not susceptible to target-based drug resistance, but they can cause non-specific side effects such as electrolyte disturbances or interference with the absorption of other medications. This category is essential for biotech analysts to distinguish between targeted molecular therapies and agents with broad physical or chemical modes of action.

Other names

Non-specific targetNon-molecular targetPhysicochemical mechanismUnknown target

Physicochemical interaction including osmosis, neutralization, adsorption, and surface tension alteration.